Academic Journal
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
Title: | Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil |
---|---|
Authors: | Holzmann, Iandra, Tovo, Cristiane V., Minmé, Roseline, Leal, Mônica P., Kliemann, Michele P., Ubirajara, Camila, Aquino, Amanda A., Araujo, Bruna, Almeida, Paulo R.L. |
Source: | Brazilian Journal of Infectious Diseases. August 2018 22(4) |
Publisher Information: | Brazilian Society of Infectious Diseases, 2018. |
Publication Year: | 2018 |
Subject Terms: | Sofosbuvir, Daclatasvir, Simeprevir, DAA, Sustained virological response |
More Details: | Introduction Chronic hepatitis C virus infection is one of the major causes of cirrhosis, hepatocellular carcinoma and liver transplantation. Treatment using direct-acting antivirals has revolutionized the treatment of hepatitis C virus, increasing long-term prognosis after cure. The goal of the present study was to evaluate the effectiveness of direct-acting antivirals in a Public Health System in southern Brazil. Methods A retrospective study evaluated all patients with chronic hepatitis C virus infection who underwent treatment at one center of the Public Health Department of the State of Rio Grande do Sul - Brazil, according to the Brazilian Clinical Protocol and Therapeutic Guidelines. The effectiveness was assessed in terms sustained virological response 12 weeks after the end of treatment. Results A total of 1002 patients who were treated for chronic hepatitis C virus infection were evaluated. The mean age was 58.6 years, 557 patients (55.6%) were male and 550 (54.9%) were cirrhotic. Overall sustained virological response was observed in 936 (93.4%) patients. There was a difference in sustained virological response rate varied according to sex, 91.6% in men and 95.7% in women (p= 0.009), length of treatment in genotype 1, 92.7% with 12 weeks and 99.1 with 24 weeks (p= 0.040), and genotype, 94.7% in genotype 1, 91.7% in genotype 2, and 91.4% in genotype 3 (p= 0.047). Conclusion The treatment of chronic hepatitis C virus infection for genotypes 1, 2 or 3 with the therapeutic regimens established by the Brazilian guidelines showed high rates of SVR, even in cirrhotic patients. |
Document Type: | article |
File Description: | text/html |
Language: | English |
ISSN: | 1413-8670 |
DOI: | 10.1016/j.bjid.2018.06.004 |
Access URL: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000400317 |
Rights: | info:eu-repo/semantics/openAccess |
Accession Number: | edssci.S1413.86702018000400317 |
Database: | SciELO |
FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4CB6B18E72D5F13605C1&Show=Object Text: Availability: 0 CustomLinks: – Url: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000400317# Name: EDS - SciELO Category: fullText Text: Full Text from SciELO MouseOverText: Full Text from SciELO – Url: https://www.doi.org/10.1016/j.bjid.2018.06.004? Name: ScienceDirect (all content)-s8985755 Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edssci&genre=article&issn=14138670&ISBN=&volume=22&issue=4&date=20180801&spage=&pages=&title=Brazilian Journal of Infectious Diseases&atitle=Effectiveness%20of%20chronic%20hepatitis%20C%20treatment%20with%20direct-acting%20antivirals%20in%20the%20Public%20Health%20System%20in%20Brazil&aulast=Holzmann%2C%20Iandra&id=DOI:10.1016/j.bjid.2018.06.004 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edssci DbLabel: SciELO An: edssci.S1413.86702018000400317 RelevancyScore: 921 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 921.427368164063 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Holzmann%2C+Iandra%22">Holzmann, Iandra</searchLink><br /><searchLink fieldCode="AR" term="%22Tovo%2C+Cristiane+V%2E%22">Tovo, Cristiane V.</searchLink><br /><searchLink fieldCode="AR" term="%22Minmé%2C+Roseline%22">Minmé, Roseline</searchLink><br /><searchLink fieldCode="AR" term="%22Leal%2C+Mônica+P%2E%22">Leal, Mônica P.</searchLink><br /><searchLink fieldCode="AR" term="%22Kliemann%2C+Michele+P%2E%22">Kliemann, Michele P.</searchLink><br /><searchLink fieldCode="AR" term="%22Ubirajara%2C+Camila%22">Ubirajara, Camila</searchLink><br /><searchLink fieldCode="AR" term="%22Aquino%2C+Amanda+A%2E%22">Aquino, Amanda A.</searchLink><br /><searchLink fieldCode="AR" term="%22Araujo%2C+Bruna%22">Araujo, Bruna</searchLink><br /><searchLink fieldCode="AR" term="%22Almeida%2C+Paulo+R%2EL%2E%22">Almeida, Paulo R.L.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <i>Brazilian Journal of Infectious Diseases</i>. August 2018 22(4) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Brazilian Society of Infectious Diseases, 2018. – Name: DatePubCY Label: Publication Year Group: Date Data: 2018 – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Sofosbuvir%22">Sofosbuvir</searchLink><br /><searchLink fieldCode="DE" term="%22Daclatasvir%22">Daclatasvir</searchLink><br /><searchLink fieldCode="DE" term="%22Simeprevir%22">Simeprevir</searchLink><br /><searchLink fieldCode="DE" term="%22DAA%22">DAA</searchLink><br /><searchLink fieldCode="DE" term="%22Sustained+virological+response%22">Sustained virological response</searchLink> – Name: Abstract Label: Description Group: Ab Data: Introduction Chronic hepatitis C virus infection is one of the major causes of cirrhosis, hepatocellular carcinoma and liver transplantation. Treatment using direct-acting antivirals has revolutionized the treatment of hepatitis C virus, increasing long-term prognosis after cure. The goal of the present study was to evaluate the effectiveness of direct-acting antivirals in a Public Health System in southern Brazil. Methods A retrospective study evaluated all patients with chronic hepatitis C virus infection who underwent treatment at one center of the Public Health Department of the State of Rio Grande do Sul - Brazil, according to the Brazilian Clinical Protocol and Therapeutic Guidelines. The effectiveness was assessed in terms sustained virological response 12 weeks after the end of treatment. Results A total of 1002 patients who were treated for chronic hepatitis C virus infection were evaluated. The mean age was 58.6 years, 557 patients (55.6%) were male and 550 (54.9%) were cirrhotic. Overall sustained virological response was observed in 936 (93.4%) patients. There was a difference in sustained virological response rate varied according to sex, 91.6% in men and 95.7% in women (p= 0.009), length of treatment in genotype 1, 92.7% with 12 weeks and 99.1 with 24 weeks (p= 0.040), and genotype, 94.7% in genotype 1, 91.7% in genotype 2, and 91.4% in genotype 3 (p= 0.047). Conclusion The treatment of chronic hepatitis C virus infection for genotypes 1, 2 or 3 with the therapeutic regimens established by the Brazilian guidelines showed high rates of SVR, even in cirrhotic patients. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: text/html – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1413-8670 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.bjid.2018.06.004 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000400317" linkWindow="_blank">http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000400317</link> – Name: Copyright Label: Rights Group: Cpyrght Data: info:eu-repo/semantics/openAccess – Name: AN Label: Accession Number Group: ID Data: edssci.S1413.86702018000400317 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edssci&AN=edssci.S1413.86702018000400317 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bjid.2018.06.004 Languages: – Text: English Subjects: – SubjectFull: Sofosbuvir Type: general – SubjectFull: Daclatasvir Type: general – SubjectFull: Simeprevir Type: general – SubjectFull: DAA Type: general – SubjectFull: Sustained virological response Type: general Titles: – TitleFull: Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Holzmann, Iandra – PersonEntity: Name: NameFull: Tovo, Cristiane V. – PersonEntity: Name: NameFull: Minmé, Roseline – PersonEntity: Name: NameFull: Leal, Mônica P. – PersonEntity: Name: NameFull: Kliemann, Michele P. – PersonEntity: Name: NameFull: Ubirajara, Camila – PersonEntity: Name: NameFull: Aquino, Amanda A. – PersonEntity: Name: NameFull: Araujo, Bruna – PersonEntity: Name: NameFull: Almeida, Paulo R.L. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 14138670 Numbering: – Type: volume Value: 22 – Type: issue Value: 4 Titles: – TitleFull: Brazilian Journal of Infectious Diseases Type: main |
ResultId | 1 |